Skip to content

Innate Pharma SA Sustainability Reports

Innate Pharma S.A. is a clinical-stage biotechnology company focused on developing immunotherapies for cancer patients. The company designs therapeutic antibodies that harness the innate immune system to combat tumors.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

ISIN: FR0010331421

7 reports from 2011 to 2017